| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anemia, Sickle Cell | 5 | 2018 | 148 | 1.320 |
Why?
|
| Reactive Oxygen Species | 5 | 2018 | 494 | 1.190 |
Why?
|
| Histone Demethylases | 5 | 2018 | 32 | 1.110 |
Why?
|
| Hepatocyte Growth Factor | 5 | 2014 | 84 | 0.710 |
Why?
|
| Erythrocytes | 2 | 2018 | 255 | 0.660 |
Why?
|
| Proto-Oncogene Proteins c-met | 9 | 2009 | 200 | 0.650 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2017 | 12 | 0.590 |
Why?
|
| Hemoglobin, Sickle | 1 | 2017 | 19 | 0.590 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2017 | 194 | 0.500 |
Why?
|
| Fetal Hemoglobin | 4 | 2018 | 13 | 0.450 |
Why?
|
| Mitochondria | 1 | 2017 | 562 | 0.420 |
Why?
|
| Enzyme Inhibitors | 4 | 2018 | 652 | 0.370 |
Why?
|
| Lung Neoplasms | 7 | 2008 | 2380 | 0.350 |
Why?
|
| Intestinal Mucosa | 5 | 2015 | 809 | 0.330 |
Why?
|
| gamma-Globins | 3 | 2018 | 5 | 0.310 |
Why?
|
| Indoles | 6 | 2009 | 307 | 0.310 |
Why?
|
| Paxillin | 2 | 2008 | 58 | 0.310 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2014 | 159 | 0.260 |
Why?
|
| Piperazines | 5 | 2009 | 285 | 0.250 |
Why?
|
| Sulfonamides | 5 | 2009 | 322 | 0.240 |
Why?
|
| Pleural Neoplasms | 1 | 2006 | 204 | 0.220 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2007 | 1132 | 0.210 |
Why?
|
| Mesothelioma | 1 | 2006 | 326 | 0.200 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2014 | 80 | 0.200 |
Why?
|
| Reticulocytes | 3 | 2018 | 25 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 2 | 2015 | 326 | 0.190 |
Why?
|
| Disease Models, Animal | 6 | 2018 | 2416 | 0.180 |
Why?
|
| Quercetin | 1 | 2000 | 3 | 0.180 |
Why?
|
| Carotenoids | 1 | 2000 | 15 | 0.180 |
Why?
|
| Animals | 18 | 2018 | 27783 | 0.180 |
Why?
|
| Rhabdomyosarcoma | 1 | 2000 | 43 | 0.170 |
Why?
|
| Anticarcinogenic Agents | 1 | 2000 | 73 | 0.170 |
Why?
|
| RNA, Small Interfering | 6 | 2009 | 557 | 0.170 |
Why?
|
| Mice | 10 | 2018 | 11993 | 0.160 |
Why?
|
| Cell Line, Tumor | 8 | 2011 | 2615 | 0.160 |
Why?
|
| Receptors, Growth Factor | 2 | 2009 | 52 | 0.160 |
Why?
|
| Tretinoin | 2 | 2015 | 130 | 0.150 |
Why?
|
| Hemolysis | 1 | 2017 | 64 | 0.140 |
Why?
|
| Rhodamines | 1 | 2017 | 20 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2012 | 667 | 0.140 |
Why?
|
| Spiro Compounds | 1 | 2017 | 26 | 0.140 |
Why?
|
| Papio | 4 | 2018 | 83 | 0.140 |
Why?
|
| Thiophenes | 1 | 2017 | 44 | 0.140 |
Why?
|
| Carcinoma, Small Cell | 2 | 2007 | 133 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2017 | 429 | 0.130 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2015 | 5 | 0.130 |
Why?
|
| Neoplasm Invasiveness | 2 | 2008 | 570 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2015 | 6 | 0.130 |
Why?
|
| Sirolimus | 1 | 2017 | 172 | 0.130 |
Why?
|
| Tranylcypromine | 1 | 2015 | 2 | 0.120 |
Why?
|
| Humans | 24 | 2018 | 91074 | 0.120 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2015 | 85 | 0.120 |
Why?
|
| Amniotic Fluid | 1 | 2014 | 30 | 0.110 |
Why?
|
| Immunohistochemistry | 7 | 2013 | 1806 | 0.110 |
Why?
|
| Signal Transduction | 5 | 2009 | 3442 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2009 | 591 | 0.110 |
Why?
|
| Mutation | 7 | 2011 | 4203 | 0.110 |
Why?
|
| Phosphorylation | 4 | 2015 | 1131 | 0.110 |
Why?
|
| Neuraminidase | 1 | 2013 | 47 | 0.110 |
Why?
|
| Smad7 Protein | 1 | 2012 | 7 | 0.100 |
Why?
|
| Milk, Human | 1 | 2013 | 46 | 0.100 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2012 | 17 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2012 | 21 | 0.100 |
Why?
|
| Cell Movement | 2 | 2007 | 793 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2013 | 198 | 0.090 |
Why?
|
| Gene Dosage | 2 | 2009 | 210 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2011 | 173 | 0.090 |
Why?
|
| Blotting, Western | 4 | 2013 | 794 | 0.090 |
Why?
|
| RNA Interference | 2 | 2008 | 378 | 0.080 |
Why?
|
| Models, Biological | 1 | 2017 | 1771 | 0.080 |
Why?
|
| Cell Growth Processes | 2 | 2007 | 85 | 0.080 |
Why?
|
| Colon | 1 | 2012 | 522 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-fyn | 1 | 2008 | 23 | 0.080 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2008 | 19 | 0.080 |
Why?
|
| Macrophages | 1 | 2012 | 589 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2013 | 888 | 0.080 |
Why?
|
| Vulva | 1 | 2008 | 23 | 0.080 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 16 | 0.070 |
Why?
|
| Neoplasm Proteins | 1 | 2011 | 538 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2008 | 83 | 0.070 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 309 | 0.070 |
Why?
|
| Blood Cell Count | 2 | 2018 | 80 | 0.070 |
Why?
|
| Cell Survival | 2 | 2007 | 984 | 0.070 |
Why?
|
| Thiocarbamates | 1 | 2007 | 6 | 0.070 |
Why?
|
| Spindle Apparatus | 2 | 2004 | 65 | 0.070 |
Why?
|
| Mitosis | 2 | 2004 | 152 | 0.070 |
Why?
|
| Muridae | 1 | 2007 | 8 | 0.070 |
Why?
|
| Sulfones | 1 | 2007 | 45 | 0.070 |
Why?
|
| Apoptosis | 1 | 2013 | 1723 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2008 | 1295 | 0.070 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 3031 | 0.070 |
Why?
|
| Proline | 1 | 2007 | 56 | 0.070 |
Why?
|
| Nuclear Proteins | 1 | 2011 | 731 | 0.070 |
Why?
|
| Tyrosine | 1 | 2007 | 133 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 2 | 2018 | 107 | 0.070 |
Why?
|
| Cell Nucleus | 4 | 2013 | 607 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2008 | 196 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 2 | 2004 | 229 | 0.070 |
Why?
|
| Hydrogen Peroxide | 1 | 2007 | 161 | 0.070 |
Why?
|
| Sodium Selenite | 1 | 2005 | 2 | 0.060 |
Why?
|
| Diethylnitrosamine | 1 | 2005 | 7 | 0.060 |
Why?
|
| Anemia | 2 | 2018 | 133 | 0.060 |
Why?
|
| Phenobarbital | 1 | 2005 | 33 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2006 | 70 | 0.060 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2005 | 26 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 77 | 0.060 |
Why?
|
| Antioxidants | 1 | 2007 | 226 | 0.060 |
Why?
|
| Epidermal Growth Factor | 1 | 2006 | 118 | 0.060 |
Why?
|
| Polyamines | 1 | 2005 | 37 | 0.060 |
Why?
|
| Cell Division | 1 | 2007 | 692 | 0.060 |
Why?
|
| Base Sequence | 2 | 2007 | 2329 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2018 | 1935 | 0.060 |
Why?
|
| Neoplasms | 2 | 2011 | 3053 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 4 | 2009 | 742 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2006 | 695 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 341 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 2 | 2008 | 1049 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2004 | 149 | 0.060 |
Why?
|
| Transfection | 3 | 2012 | 910 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2018 | 1993 | 0.060 |
Why?
|
| Microtubules | 1 | 2004 | 129 | 0.050 |
Why?
|
| Cisplatin | 2 | 2009 | 599 | 0.050 |
Why?
|
| Mice, Nude | 3 | 2011 | 821 | 0.050 |
Why?
|
| Histones | 2 | 2016 | 345 | 0.050 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2004 | 184 | 0.050 |
Why?
|
| Protein Isoforms | 3 | 2013 | 281 | 0.050 |
Why?
|
| Melanoma | 1 | 2007 | 475 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2013 | 375 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2009 | 1095 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2007 | 603 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2009 | 1087 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2008 | 1695 | 0.050 |
Why?
|
| Animals, Newborn | 2 | 2013 | 523 | 0.050 |
Why?
|
| Premature Birth | 2 | 2013 | 122 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2004 | 1237 | 0.050 |
Why?
|
| Liver | 1 | 2005 | 1222 | 0.040 |
Why?
|
| Vitamin A | 1 | 2000 | 28 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2000 | 71 | 0.040 |
Why?
|
| Drug Design | 1 | 2018 | 129 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2012 | 925 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 1757 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 673 | 0.030 |
Why?
|
| Gene Expression | 2 | 2013 | 1313 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 2347 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2009 | 492 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 282 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 2 | 2008 | 354 | 0.030 |
Why?
|
| Smad Proteins | 1 | 2015 | 43 | 0.030 |
Why?
|
| U937 Cells | 1 | 2015 | 32 | 0.030 |
Why?
|
| Erythroid Precursor Cells | 1 | 2015 | 33 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2015 | 51 | 0.030 |
Why?
|
| Hydroxyurea | 1 | 2015 | 239 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 6847 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 185 | 0.030 |
Why?
|
| Tubulin | 2 | 2004 | 60 | 0.030 |
Why?
|
| Methylation | 1 | 2015 | 276 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2013 | 34 | 0.030 |
Why?
|
| Animal Feed | 1 | 2014 | 21 | 0.030 |
Why?
|
| Infant Formula | 1 | 2014 | 17 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2013 | 49 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2013 | 25 | 0.030 |
Why?
|
| Fas Ligand Protein | 1 | 2013 | 49 | 0.030 |
Why?
|
| Rats | 2 | 2014 | 4043 | 0.030 |
Why?
|
| Plasmids | 2 | 2004 | 292 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2004 | 391 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2013 | 122 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2013 | 124 | 0.030 |
Why?
|
| Term Birth | 1 | 2013 | 8 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 303 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2004 | 516 | 0.030 |
Why?
|
| Dietary Supplements | 1 | 2014 | 124 | 0.030 |
Why?
|
| Papio cynocephalus | 1 | 2012 | 3 | 0.030 |
Why?
|
| Papio anubis | 1 | 2012 | 7 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2015 | 308 | 0.030 |
Why?
|
| Lactation | 1 | 2013 | 54 | 0.030 |
Why?
|
| DNA Primers | 1 | 2013 | 546 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 220 | 0.030 |
Why?
|
| Denaturing Gradient Gel Electrophoresis | 1 | 2012 | 1 | 0.030 |
Why?
|
| Chemokine CXCL5 | 1 | 2012 | 2 | 0.030 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2012 | 16 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 405 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2018 | 2033 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2012 | 38 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 29 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 594 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2007 | 2077 | 0.020 |
Why?
|
| Aged | 2 | 2008 | 19574 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 695 | 0.020 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2011 | 16 | 0.020 |
Why?
|
| Biomarkers | 1 | 2018 | 1814 | 0.020 |
Why?
|
| Intestinal Diseases | 1 | 2012 | 79 | 0.020 |
Why?
|
| Gestational Age | 1 | 2012 | 327 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 1589 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 1226 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2012 | 520 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2016 | 672 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2011 | 285 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 251 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 2345 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2012 | 997 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2012 | 388 | 0.020 |
Why?
|
| Middle Aged | 2 | 2008 | 26555 | 0.020 |
Why?
|
| Female | 4 | 2018 | 47186 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 429 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2012 | 299 | 0.020 |
Why?
|
| Cytokines | 1 | 2014 | 817 | 0.020 |
Why?
|
| Phenotype | 2 | 2008 | 2480 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2013 | 469 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2014 | 693 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 660 | 0.020 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2008 | 33 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 2891 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 2506 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2008 | 183 | 0.020 |
Why?
|
| Thrombospondin 1 | 1 | 2007 | 21 | 0.020 |
Why?
|
| Microphthalmia-Associated Transcription Factor | 1 | 2007 | 14 | 0.020 |
Why?
|
| Aging | 1 | 2012 | 732 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 3204 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 1248 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 324 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 694 | 0.020 |
Why?
|
| Pregnancy | 1 | 2014 | 3079 | 0.020 |
Why?
|
| Nicotine | 1 | 2008 | 202 | 0.020 |
Why?
|
| Inflammation | 1 | 2012 | 998 | 0.020 |
Why?
|
| Stem Cells | 1 | 2008 | 381 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2009 | 499 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 727 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2012 | 2510 | 0.020 |
Why?
|
| Caenorhabditis elegans | 1 | 2008 | 234 | 0.020 |
Why?
|
| alpha-Fetoproteins | 1 | 2005 | 44 | 0.020 |
Why?
|
| Male | 4 | 2011 | 43249 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 409 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2005 | 304 | 0.020 |
Why?
|
| Interphase | 1 | 2004 | 35 | 0.010 |
Why?
|
| Organ Size | 1 | 2005 | 375 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2004 | 69 | 0.010 |
Why?
|
| Dynactin Complex | 1 | 2004 | 2 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 270 | 0.010 |
Why?
|
| Dyneins | 1 | 2004 | 14 | 0.010 |
Why?
|
| Gene Library | 1 | 2004 | 133 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 111 | 0.010 |
Why?
|
| Body Weight | 1 | 2005 | 456 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2005 | 178 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 112 | 0.010 |
Why?
|
| Time Factors | 1 | 2013 | 5378 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 1877 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2004 | 201 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 439 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2004 | 565 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2004 | 511 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2004 | 1016 | 0.010 |
Why?
|
| Risk Factors | 1 | 2012 | 5608 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2007 | 1564 | 0.010 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 2550 | 0.010 |
Why?
|
| Adult | 1 | 2008 | 27147 | 0.000 |
Why?
|